Combiningboth meta-analytic strategies, we identified ten candidate biomarkerssupported by multiple studies as potential components of a multimarkerdiagnostic panel for T2D: LMAN2, APOA2, PSAP, DLD, COL6A1, CDH1, PHB1, ORM1, HP, and AZPG1. This evidence concerns the gene CDH1 and type 2 diabetes mellitus.